SCHEMBL5480007

SCHEMBL5480007

COc1cccc(O)c1C1CCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.53
TP53 P04637 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52
ALOX12 P18054 1/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
TSHR P16473 1/20 0.48
CNR2 P34972 6/20 0.45
CNR1 P21554 5/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HDAC4 P56524 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4608027 0.98 ABCB1 (0.55) ABCB1TP53KDM4EALDH1A1LMNA
SCHEMBL2047875 0.93 TP53 (0.55) ABCB1TP53KDM4EALDH1A1LMNA
SCHEMBL19072578 0.85 ABCB1 (0.68) ABCB1TP53KDM4EALDH1A1LMNA
SCHEMBL3169205 0.80 HDAC4 (0.52) ALDH1A1LMNAHPGDALOX15HSD17B10
SCHEMBL3681666 0.80 ESR1 (0.44) ABCB1KDM4EALDH1A1LMNACYP3A4
SCHEMBL28204910 0.79 ABCB1 (0.60) ABCB1CA1CA2MEN1KMT2A
SCHEMBL7531576 0.78 HDAC4 (0.50) ABCB1KDM4EALDH1A1LMNAHPGD
SCHEMBL6004412 0.78 HDAC4 (0.50) ABCB1KDM4EALDH1A1LMNAHPGD
Water SCHEMBL27641338 0.78 HDAC4 (0.50) ALDH1A1LMNAHPGDALOX15HSD17B10
SCHEMBL9870482 0.78 ABCB1 (0.64) ABCB1TP53KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093548-A1 Use of progesterone receptor modulators WYETH (US) 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093548-A1 Use of progesterone receptor modulators PGR, GNRHR, PGRMC2 ABCB1 2664/4885TP53 3741/4885KDM4E 4166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.